1
Home
Companies

Adial Pharmaceuticals

#10489

Rank

$3.17M

Marketcap

US United States

Country

Adial Pharmaceuticals
Leadership team

Mr. Cary John Claiborne MBA (CEO, Pres & Director)

Mr. Joseph A. M. Truluck M.B.A., MBA (CFO, Treasurer & Sec.)

Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D. (Founder & Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Headquarters
Charlottesville, Virginia, United States
Established
2010
Company Registration
SEC CIK number: 0001513525
Traded as
ADIL
Social Media
URL
https://www.adialpharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
History

Adial Pharmaceuticals was founded in 2007 by Founding Chairman and CEO, William Stilley, M.D. The Company focuses on researching, developing and commercializing treatments for alcohol use disorder (AUD) and other addictions and related disorders.

Mission
Adial Pharmaceuticals is committed to developing and advancing treatments for addictions and related disorders.
Vision
Our vision is to become a global leader in the development and commercialization of treatments for AUD, as well as other addictions and related disorders.
Key Team

Dr. Jack W. Reich Ph.D. (Head of Regulatory)

Mr. Mark H. Peikin (Chief Strategy Officer & Chief Devel. Officer)

Mr. John R. Martin J.D. (Gen. Counsel)

Mr. Alex Lugovoy (Chief Bus. Officer)

Mr. Lawrence Goldman CPA (Controller)

Ms. Catherine Fratila (Controller)

Recognition and Awards
Adial Pharmaceuticals has received numerous awards including: 2017 & 2018 Virginia Life Sciences Investment Award, 2015's VA Bio Board of Directors Award for Excellence in Life Sciences, 2017 Gold Award for American Medical Association's STEP Challenge and 2018 Top Entrepreneur Award from the Center for Innovative Technology.
References

https://in.investing.com/equities/adial-pharma

https://finance.yahoo.com/quote/ADIL/profile?p=ADIL

https://www.crunchbase.com/organization/adial-pharmaceuticals

https://companiesmarketcap.com/

https://www.adialpharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Adial Pharmaceuticals
Leadership team

Mr. Cary John Claiborne MBA (CEO, Pres & Director)

Mr. Joseph A. M. Truluck M.B.A., MBA (CFO, Treasurer & Sec.)

Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D. (Founder & Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Headquarters
Charlottesville, Virginia, United States
Established
2010
Company Registration
SEC CIK number: 0001513525
Traded as
ADIL
Social Media
URL
https://www.adialpharma.com